We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Amphenol
APH
$191B
| $709K | 0.01% |
+117,792
| New | +$702K |
|
602
Flex
FLEX
$39.9B
| $708K | 0.01% |
84,852
+69,046
| +437% | +$520K |
|
603
IBM
IBM
$224B
| $708K | 0.01% |
4,085
+626
| +18% | +$113K |
|
604
Assured Guaranty
AGO
$3.14B
| $702K | 0.01% |
28,655
+13,570
| +90% | +$337K |
|
|
CAM
605
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $702K | 0.01% |
10,363
-43,505
| -81% | -$2.8M |
|
606
Vera Bradley
VRA
$114M
| $696K | 0.01% |
+31,844
| New | +$838K |
|
|
SNDK
607
DELISTED
SANDISK CORP
SNDK
| $695K | 0.01% |
6,651
-3,344
| -33% | -$304K |
|
608
Astronics
ATRO
$2.85B
| $691K | 0.01% |
26,795
+4,894
| +22% | +$127K |
|
|
LEG
609
DELISTED
Leggett & Platt
LEG
| $690K | 0.01% |
+20,136
| New | +$671K |
|
|
CIVI
610
DELISTED
Civitas Resources
CIVI
| $686K | 0.01% |
108
-336
| -76% | -$1.9M |
|
|
DISCK
611
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $684K | 0.01% |
18,852
+1,400
| +8% | +$51.3K |
|
|
MFA
612
MFA Financial
MFA
$854M
| $680K | 0.01% |
20,710
+17,251
| +499% | +$558K |
|
613
NVIDIA
NVDA
$5.17T
| $680K | 0.01% |
1,466,320
+670,720
| +84% | +$313K |
|
|
MXIM
614
DELISTED
Maxim Integrated Products
MXIM
| $676K | 0.01% |
+19,987
| New | +$666K |
|
|
BTU
615
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $672K | 0.01% |
+2,740
| New | +$713K |
|
616
Edgewell Personal Care
EPC
$1.23B
| $665K | 0.01% |
7,356
+1,920
| +35% | +$158K |
|
|
HTS
617
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $665K | 0.01% |
+33,550
| New | +$664K |
|
618
Diageo
DEO
$48.3B
| $662K | 0.01% |
+5,200
| New | +$655K |
|
619
Prologis
PLD
$127B
| $660K | 0.01% |
16,071
+10,929
| +213% | +$449K |
|
620
Micron Technology
MU
$1.05T
| $658K | 0.01% |
19,960
-18,915
| -49% | -$516K |
|
621
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.03B
| $658K | 0.01% |
+2,000
| New | +$615K |
|
|
NAV
622
DELISTED
Navistar International
NAV
| $658K | 0.01% |
17,560
+9,211
| +110% | +$327K |
|
623
Becton Dickinson
BDX
$49.5B
| $655K | 0.01% |
5,677
-82,946
| -94% | -$9.4M |
|
624
InterDigital
IDCC
$8.48B
| $654K | 0.01% |
+13,691
| New | +$529K |
|
|
BMR
625
DELISTED
BIOMED REALTY TRUST INC
BMR
| $651K | 0.01% |
+29,838
| New | +$634K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.